Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DESIPRAMINE 10 MG TABLET

Desipramine
$0.5167per EA

Strength

10 mg/1

Manufacturer

Amneal Pharmaceuticals NY LLC

NDC

69238105303

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/23/2020

Active Ingredients

DESIPRAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208105

On Market Since

3/21/2016

Pharmacological Classes

Tricyclic Antidepressant

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-32.4%

Generic Alternatives

Save up to 69%

1 alternative • Same active ingredient

DESIPRAMINE 10 MG TABLET
Generic
69238105301•Amneal Pharmaceuticals NY LLC
$0.1596
Save 69%

Related Drugs

Same classification

AMITRIPTYLINE HCL 10 MG TAB
Generic
00781148601•Sandoz Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
00781148610•Sandoz Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16571010501•Rising Pharma Holdings Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16571010510•Rising Pharma Holdings Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16714025701•NorthStar Rx LLC
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16714025702•NorthStar Rx LLC
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16729017101•Accord Healthcare Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
29300041901•Unichem Pharmaceuticals (USA) Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
29300041910•Unichem Pharmaceuticals (USA) Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
50268003715•AvPAK
$0.0342
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy